Website Header with Language Selector and Dropdowns

Chemical Name: (S)-4-fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline hydrochloride dihydrate.

Country of Origin: India

Product Category:Ripasudil Impurities


Ripasudil Hydrochloride Dihydrate is identified by CAS No. 887375-67-9 and is chemically known as (S)-4-fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline hydrochloride dihydrate.

Ripasudil Hydrochloride Dihydrate is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Ripasudil.

Page Keywords: Buy Ripasudil Hydrochloride Dihydrate | Purchase Ripasudil Hydrochloride Dihydrate | Ripasudil Hydrochloride Dihydrate suppliers | Ripasudil Hydrochloride Dihydrate manufacturers | Ripasudil Hydrochloride Dihydrate price | Ripasudil Hydrochloride Dihydrate Importer | Ripasudil Hydrochloride Dihydrate Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-RPU-03
CAS No: 906820-10-8
Mol Wt: 227.2
Mol F: C9H6FNO3S
Inv. Status: Custom Synthesis
CAT No: CL-RPU-04
CAS No: 1334294-09-5
Mol Wt: 227.2
Mol F: C9H6FNO3S
Inv. Status: Custom Synthesis
CAT No: CL-RPU-05
CAS No: 1334294-10-8
Mol Wt: 245.7 : 36.5
Mol F: C9H5ClFNO2S : HCl
Inv. Status: Custom Synthesis
CAT No: CL-RPU-06
CAS No: 906820-08-4
Mol Wt: 245.7 : 36.5
Mol F: C9H5ClFNO2S : HCl
Inv. Status: Custom Synthesis
CAT No: CL-RPU-07
CAS No: 223644-10-8
Mol Wt: 214.3
Mol F: C11H22N2O2
Inv. Status: Custom Synthesis
CAT No: CL-RPU-02
CAS No: 223644-04-0
Mol Wt: 323.4 : 36.5
Mol F: C15H18FN3O2S : HCl
Inv. Status: Custom Synthesis
Address(India):

Plot No. A-737/2, TTC Industrial area,
MIDC, Kopar Khairne, Navi Mumbai, INDIA, 400710

           
Address(Bangladesh):

House No. - 12, Road No. - 17, Nikunja -2,
Khilkhet, Dhaka-1230, Bangladesh.

Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.